B Anderegg

Analysis of Gene Amplification and Prognostic Markers in Ovarian Cancer Using Comparative Genomic Hybridization for Microarrays and Immunohistochemical Analysis for Tissue Microarrays

Doris Mayr, Veronika Kanitz, B Anderegg et al. · American Journal of Clinical Pathology · 2006 · 86 citations · Full text

Gene Amplification, Pathology, Gynecology +19

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

Tomonari Suzuki, B Anderegg, Toshika Ohkawa et al. · Gene Therapy · 2000 · 58 citations

Tumor Biology, Breast Oncology, Vivo Growth +11

Does endometriosis really have premalignant potential? A clonal analysis of laser‐microdissected tissue

Doris Mayr, Gudrun Amann, Christina Siefert et al. · The FASEB Journal · 2003 · 41 citations

Therapeutic Efficacy of an Adenovirus-Mediated Anti-H- <i>ras</i> Ribozyme in Experimental Bladder Cancer

Akira Irie, B Anderegg, Mohammed Kashani–Sabet et al. · Antisense and Nucleic Acid Drug Development · 1999 · 39 citations

Frequent reduction or loss of DCC gene expression in human osteosarcoma

MA Horstmann, M Pösl, RB Scholz et al. · British Journal of Cancer · 1997 · 29 citations · Full text

Oncology, Oncogenic Agent, Frequent Reduction +9